BioCryst Pharmaceuticals, Inc.
BCRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $12,899 | $5,085 | $32 | -$26,795 |
| Dep. & Amort. | $335 | $329 | $331 | $309 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $21,304 | $21,368 | $21,339 |
| Change in WC | -$1,370 | $2,377 | -$62,132 | -$11,331 |
| Other Non-Cash | $29,247 | $12,207 | $12,884 | $11,265 |
| Operating Cash Flow | $41,111 | $41,302 | -$27,517 | -$5,213 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,344 | -$179 | -$143 | -$675 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$58,634 | -$29,341 | -$48,762 | -$39,528 |
| Inv. Sales/Matur. | $73,000 | $58,647 | $76,000 | $58,000 |
| Other Inv. Act. | $550 | $0 | $0 | $0 |
| Investing Cash Flow | $13,572 | $29,127 | $27,095 | $17,797 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$60,341 | -$70,044 | -$516 | -$356 |
| Stock Issued | $2,668 | $9 | $6 | $5 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$628 | -$3,651 | $1,039 | -$3,670 |
| Financing Cash Flow | -$58,301 | -$73,686 | $529 | -$4,021 |
| Forex Effect | -$250 | -$13,699 | $451 | -$1,304 |
| Net Chg. in Cash | -$3,868 | -$16,956 | $558 | $7,259 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88,525 | $106,881 | $106,323 | $99,064 |
| End Cash | $84,657 | $89,925 | $106,881 | $106,323 |
| Free Cash Flow | $39,767 | $41,123 | -$27,660 | -$5,888 |